Search Results 461-470 of 16542 for Acrivastine

  1. Discovery of Biomarkers as Targets for CNS Regeneration - Neuroregeneration and Neurorehabilitation - Projects

    Mayo Clinic's Neuroregeneration and Neurorehabilitation Lab, led by Isobel A. Scarisbrick, Ph.D., studies transcriptomic and proteomics approaches for ...

  2. A Study Of Benralizumab In Patients With Eosinophilic Esophagitis - Mayo Clinic

    The purpose of this study is to compare the effect of benralizumab 30 mg every 4 weeks (Q4W) with placebo on histologic signs and gastrointestinal symptoms in ...

  3. TECTONIC CAD IVL IDE Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

  5. Gastroenterology and Hepatology - Clinical trials

    The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...

  6. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

    This trial will seek to extend the preliminary findings of efficacy of MBG453 in combination with hypomethylating agents (HMA) by evaluating MBG453 in ...

  7. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

    The primary objective of this study is to assess the effectiveness of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).

  8. https://www.mayoclinic.org/chinese_patient_consumer_recipe.xml

  9. An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer - Mayo Clinic

    The purpose of this study is to assess if camizestrant improves outcomes compared to standard endocrine therapy for patients with ER+/HER2- early breast cancer ...

  10. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

    The primary purpose of this study is to evaluate the clinical effectiveness of apremilast compared with placebo in children and adolescents (ages 6 through 17 ...